CHARACTERISTICS OF THE COVID-19 EPIDEMIC PROCESS DURING THE SECOND WAVE OF ITS RISE IN UKRAINE

Authors

DOI:

https://doi.org/10.11603/1681-2727.2021.3.12487

Keywords:

COVID-19, epidemic process, morbidity, death rate, mortality

Abstract

The aim of the study is to determine the peculiarities of the COVID-19 epidemic process in Ukraine during the second wave of its incidence.

Materials and methods. A comparative analysis of the epidemic process of COVID-19 in Ukraine in early 2021 and during the new rise in morbidity (second wave) according to official reports.

Results and discussion. The first wave of the COVID-19 epidemic process in Ukraine lasted until the end of the first 2 weeks of 2021. Starting from the 7th week of the year it is possible to state the rise in the incidence of the second wave with a maximum at weeks 13–14 (weekly incidence rates were 271.7–276.3 per 100 thousand population). From the 15th week (1 week after the introduction of the lockdown in most regions of Ukraine on April 5, 2021) its decrease began; from the week 21 of 2021, we can talk about the cessation of the second wave of rising morbidity. The incidence of COVID-19 was significantly correlated in time with the overall incidence of ARI (r=0.88±0.05), and we can indirectly talk about the underdiagnosis of COVID-19. The minimum weekly mortality rates from COVID-19 observed in weeks 6, 7 and 22 of the year (2.0 per 100 thousand population), the maximum – in weeks 14–15 (7.1 per 100 thousand population). The total mortality during 01.01–06.06.2021 increased from 1.8 % to 2.3 %, and the weekly mortality during weeks 17–22 steadily exceeded 4.0 % and tended to increase. Among patients aged 60–69 and 70 and older at the end of the second wave, the total mortality exceeded the mean value among the total number of patients (2.33 %) by 1.6 and 4.8 times, respectively. The proportion of patients diagnosed with COVID-19 by PCR ranged from 4.8 % to 33.4 % with the lowest levels from week 18, with a significant reduction in the incidence of the second wave.

Conclusions. We can talk about the acceleration of SARS-CoV-2 transmission during the second rise in the incidence of COVID-19 in Ukraine compared to the first wave. According to the results of epidemiological analysis of official statistics for the period of the new epidemic wave (7–20 weeks), there were no significant changes in the epidemic process of this infection, except for its sharp intensification, which led to overload of the health care system, increased mortality. According to the results of epidemiological analysis of official statistics for the period of the new epidemic wave (7–20 weeks), there were no significant changes in the epidemic process of this infection. At the same time, it sharply intensified, which led to an overload of the health care system and an increase in mortality (mainly due to patients over 60 years of age, who accounted for 81.72 % of deaths with their share among patients 29.15 %). The total mortality rate increased in 2–3 weeks after the increase in the ratio of the number of patients to the number of hospitalized to the level of 2.7 and above. The official incidence statistics for COVID-19 are underestimated. According to epidemiological signs, no evidence of increased virulence of SARS-CoV-2 virus detected.

Author Biographies

V. I. Zadorozhna, L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Science of Ukraine

Corresponding Member of the National Academy of Medical Sciences of Ukraine, MD, Professor, Director of the State Institution “L.V. Hromashevskyi Epidemiology and Infectious Diseases Institute of the National Academy of Medical Sciences of Ukraine”

T. A. Serheyeva, L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Science of Ukraine

MD, Senior Researcher, Head of the Laboratory of Epidemiology of Parenteral Viral Hepatitis and HIV-infection

References

COVID-19 coronavirus pandemic: Last updated: June 17, 2021, 08:01 GMT. Wordometer. Electronic resource. Retrieved from: https://www.worldometers.info/coronavirus/

Ukraine COVID-19 daily situation report June: 17, 2021, 09:00. Center for Public Health of the Ministry of Health of Ukraine. Electronic resource. Retrieved from: https://cloud.phc.org.ua/index.php/s/72wxF7jNnrBx492?path= %2F2021.06#pdfviewer

Zadorozna, V. I. (2021). Molecular and epidemiological aspects of SARS-CoV-2. Infectsiyni khvoroby – Infectious Diseases, (1), 32-44. Retrieved from: https://doi.org/10.11603/1681-2727.2021.1.11949 [in Ukrainian].

Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., et al. (2020). The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell, 182 (5), 1284-1294.e9. Retrieved from: https://doi.org/10.1016/j.cell.2020.07.012

SARS-CoV-2 variant classifications and definitions: Updated June 15, 2021. CDC. Electronic resource. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html

Disease Outbreak News: SARS-CoV-2 Variants: Originally published 31 Dec 2020. WHO. Electronic resource. Retrieved from: https://reliefweb.int/report/world/disease-outbreak-news-sars-cov-2-variants-31-december-2020

Hasan, M. R., Sundararaju, S., Manickam, C., Mirza, F., Al-Hail, H., Lorenz, S., & Tang, P. (2021). A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by reverse transcription-quantitative PCR. Journal of Clinical Microbiology, 59 (4), e03278-20. Retrieved from: https://doi.org/10.1128/JCM.03278-20

Cherian, S., Potdar, V., Jadhav, S., Yadav, P., Gupta, N., Das, M., Das, S., Agarwal, A., Singh, S., Abraham, P., Panda, S., Mande, S., Swarup, R., Bhargava, B., Bhushan, R., & NIC team, INSACOG Consortium (2021). Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. bioRxiv 2021.04.22.440932; DOI: https://doi.org/10.1101/2021.04.22.440932

Zadorozhna, V.I., Serheieva, T.A. (2020). Epidemiological aspects of COVID-19 and problematic issues. Actual Infectology, 8 (5-6), 141–143 [in Ukrainian].

Conti, P., Caraffa, A., Gallenga, C. E., Kritas, S. K., Frydas, I., Younes, A., Di Emidio, P., Tetè, G., Pregliasco, F., & Ronconi, G. (2021). The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Journal of Biological Regulators and Homeostatic Agents, 35 (1), 1-4. Retrieved from: https://doi.org/10.23812/21-3-E

Frampton, D., Rampling, T., Cross, A., Bailey, H., Heaney, J., Byott, M., Scott, R., et al. (2021). Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. The Lancet. Infectious Diseases, S1473-3099(21)00170-5. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00170-5

Published

2021-11-29

How to Cite

Zadorozhna, V. I., & Serheyeva, T. A. (2021). CHARACTERISTICS OF THE COVID-19 EPIDEMIC PROCESS DURING THE SECOND WAVE OF ITS RISE IN UKRAINE. Infectious Diseases – Infektsiyni Khvoroby, (3), 13–20. https://doi.org/10.11603/1681-2727.2021.3.12487

Issue

Section

Original investigations